CONMED Corporation (CNMD) vs NovoCure Limited (NVCR)
- CONMED Corporation CNMD 46.72 −0.89%
- NovoCure Limited NVCR 14.07 −2.36%
CONMED Corporation and NovoCure Limited are both Medical Devices companies. NovoCure Limited is the larger, with a market value of $1.7B against $1.4B — 1.2× the size. NovoCure Limited has negative trailing earnings, so its P/E is not meaningful; CONMED Corporation trades at 25.3×. NovoCure Limited grew revenue faster over the last twelve months: 11.0% against 3.42%. CONMED Corporation has the higher net margin (4.12% vs −21.3%) and the higher return on invested capital (3.75% vs −115.6%). Across the 19 metrics below, CONMED Corporation leads on 13 and NovoCure Limited on 6.
Valuation
Profitability
| Metric | CNMD | NVCR | Medical Devices median |
|---|---|---|---|
| Gross margin | 55.79% | 76.13% | 56.01% |
| Operating margin | 8.04% | (22.08%) | (15.03%) |
| Net margin | 4.12% | (21.25%) | (20.40%) |
| Free cash flow margin | 9.80% | (3.64%) | (7.24%) |
| Return on equity | 5.53% | (43.22%) | (15.32%) |
| Return on assets | 2.44% | (14.56%) | (19.72%) |
| Return on invested capital | 3.75% | (115.56%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack